CGCarl-Gerhard Gottfries

Carl-Gerhard Gottfries

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carl-Gerhard Gottfries has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diverse characteristics of the urinary excretion of amino acids in humans and the use of amino acid supplementation to reduce fatigue and sub-health in adults

    by R. H. Dunstan, D. L. Sparkes, M. M. Macdonald, X. Janse De Jonge, B. J. Dascombe, J. Gottfries, C.-G. Gottfries, T. K. Roberts

    The excretion of amino acids in urine represents an important avenue for the loss of key nutrients. Some amino acids such as glycine and histidine are lost in higher abundance than others. These two amino acids perform important physiological functions and are required for the synthesis of key proteins such as haemoglobin and collagen. Stage 1 of this study involved healthy subjects (n = 151) who provided first of the morning urine samples and completed symptom questionnaires. Urine was analysed for amino acid composition by gas chromatography. Stage 2 involved a subset of the initial cohort (n = 37) who completed a 30 day trial of an amino acid supplement and subsequent symptom profile evaluation. Analyses of urinary amino acid profiles revealed that three groups could be objectively defined from the 151 participants using k-means clustering. The amino acid profiles were significantly different between each of the clusters (Wilks’ Lambda = 0.13, p < 0.0001). Cluster 1 had the highest loss of amino acids with histidine being the most abundant component. Cluster 2 had glycine present as the most abundant urinary amino acid and cluster 3 had equivalent abundances of glycine and histidine. Strong associations were observed between urinary proline concentrations and fatigue/pain scores (r = .56 to .83) for females in cluster 1, with several other differential sets of associations observed for the other clusters. Different phenotypic subsets exist in the population based on amino acid excretion characteristics found in urine. Provision of the supplement resulted in significant improvements in reported fatigue and sleep for 81% of the trial cohort with all females reporting improvements in fatigue. The study was registered on the 18th April 2011 with the Australian New Zealand Clinical Trials Registry ( ACTRN12611000403932 ).


  • Open Access

    Myalgisk encefalomyelit/Kroniskt trötthetssyndrom – Historiska aspekter från ett svenskt perspektiv

    by Carl-Gerhard Gottfries

    Författaren noterade ett trötthetssyndrom redan 1958 hos patienter som genomgått Asiaten, en influensa som då härjade i Sverige. Insjuknade själv i Asiaten och utvecklade en allvarlig trötthet. Självförsök, genomförda på 1960-talet, ledde till behandling med stafylokockvaccinet Staphypan, ett vaccin med superantigen effekt. Diagnosen kroniskt trötthetssyndrom etablerades inom medicin 1988 och går nu under namnet myalgisk encefalomyelit/kroniskt trötthetssyndrom (ME/CFS). År 1992 påbörjades systematisk forskning med Staphypan. Två dubbelblindstudier gav evidens för behandlingseffekt. Tyvärr drogs vaccinet in 2005 och något ersättningspreparat har vi inte kunnat finna. Sammantaget är stödet för somatogenes vid ME/CFS påtagligt även om man tidigare antagit att sjukdomen varit psykosomatisk. Störning i patienternas immunsystem är en hypotes som får stöd från flera håll. Tillsammans med professor Jonas Blomberg visades 2012 att vid ME/CFS finns en infektionsbetingad autoimmunitet riktad mot ett mitokondriellt protein. I studier av spinalvätska från patienter med ME/CFS har låga vitamin B12 värden registrerats samtidigt som homocysteinnivåer är höga. Detta har lett till behandling med vitamin B12 i högre doser än de som användes vid traditionell behandling. Positiv effekt har registrerats.